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Saccharomyces  cerevisiae  contains an amphiphilic 
CAMP-binding glycoprotein at  the outer face of the 
plasma  membrane (M,  = 54,000). It is converted  to  a 
hydrophilic  form  by treatment  with glycosyl-phospha- 
tidylinositol-specific phospholipases C and D (GPI- 
PLC/D), suggesting  membrane  anchorage by a cova- 
lently bound glycolipid. Determination of the constit- 
uents of the  purified  anchor by gas-liquid  chromatog- 
raphy  and amino  acid  analysis reveals  the presence of 
glycerol, myo-inositol, glucosamine, galactose, man- 
nose, ethanolamine, and  asparagine (as the  carboxyl- 
terminal amino  acid of the  Pronase-digested  protein to
which the  anchor is attached).  Complementary  results 
are obtained by metabolic labeling, indicating that 
fatty acids and phosphorus are additional  anchor con- 
stituents.  The  phosphorus is resistant  to  alkaline phos- 
phatase,  whereas  approximately half is lost  from the 
protein after  treatment  with  GPI-PLD  or  nitrous acid, 
and all is removed by aqueous HF indicating  the pres- 
ence of two phosphodiester bonds. Inhibition of N- 
glycosylation  by  tunicamycin or removal of protein- 
bound glycan  chains  by  N-glycanase or  Pronase does 
not abolish radiolabeling of the  anchor  structure by 
any of the above compounds. Analysis of the  products 
obtained after  sequential enzymic and chemical deg- 
radation of the  anchor  agrees  with  the  arrangement of 
constitutents  in  GPIs  from  higher  eucaryotes.  Evidence 
for  anchorage of the yeast CAMP-binding protein by a 
GPI  anchor is strengthened  additionally by the  reactiv- 
ity of the GPI-PLC-cleaved anchor with antibodies 
directed  against  the  cross-reacting  determinant of try- 
panosomal variant  surface glycoproteins. 
An increasing number of eucaryotic cell surface proteins 
has been found embedded in  the plasma membrane by car- 
boxyl-terminally attached glycolipidic membrane anchors. 
Among them  are  coat  and  structural  proteins, receptors, cell 
adhesion and regulatory molecules, and ectoenzymes (e.g. 
hydrolases) (for reviews see Refs. 1-4). These proteins face 
the extracellular space and behave as integral membrane 
proteins. In most cases the glycolipidic anchor structure is 
constituted by phosphatidylinositol linked to the carboxyl 
terminus of the polypeptide via nonacetylated glucosamine, a 
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glycan portion composed of 3 mannosyl residues (to which, in 
some proteins, further carbohydrate moieties like galactose 
may be attached)  and  phosphate ester-bound ethanolamine 
(5,6, 8,9). 
Recently, covalent modification of proteins by lipids has 
also been described in lower eucaryotes. The contact  site A 
cell adhesion protein of Dictyostelium  discoideum (lo), possi- 
bly identical with antigen 117 ( l l ) ,  is attached to  the outer 
leaflet of the plasma membrane by an inositol-phosphocer- 
amide-based lipid glycan instead of by phosphatidylinositol. 
In Saccharomyces  cerevisiae several phosphatidylinositol-an- 
chored membrane proteins have been identified, e.g. a cell 
cycle-modulated 115-kDa glycoprotein gp115 (In),  an abun- 
dant 125-kDa glycoprotein (13-16), and a CAMP-binding 
protein (17). These amphiphilic plasma membrane proteins, 
the physiological functions of which are  as yet unknown, can 
be metabolically labeled by myo-inositol and  fatty acids and 
released from the membrane in hydrophilic form by enzymic 
and chemical cleavages of GPI’ membrane anchors. Although 
the yeast proteins exhibit characteristics of GPI-anchored 
proteins, in  no  case has the structure of their anchors been 
studied in greater detail. In the present study we prove the 
GPI  nature of the CAMP-binding plasma membrane protein 
from yeast. 
EXPERIMENTAL  PROCEDURES 
Materials 
[l-14C]Stearic acid (50-60 mCi/mmol), [9,10-3H]palmitic acid (30- 
60 Ci/mmol), ~-myo-[2-~H]inositol (15 Ci/mmol), D-[l-3H]glucosa- 
mine hydrochloride (2-5 Ci/mmol), [l-3H]ethan-l-01-2-amine hydro- 
chloride (5-30 Ci/mmol), and N-[3H]acetyl-concanavalin A (45 Ci/ 
mmol) were provided by Amersham-Buchler, Braunschweig. 8-N3- 
[3ZP]cAMP (20 Ci/mmol) was purchased from ICN, Eschwege. myo- 
[“C(U)]Inositol (200-250 mCi/mmol), ~-[‘~C(U)]galactose (250-360 
mCi/mmol), ~-[‘~C(U)]mannose (200 mCi/mmol), D-[14c(u)]ghco- 
samine hydrochloride (250-350 mCi/mmol), [14C(U)]glycerol (100- 
150 mCi/mmol), 32Pi (8,500-9,120 Ci/mmol), mouse Iz5I-anti-rabbit 
IgG  (2-10 &i/pg), Aquasol 11, and autoradiography enhancer 
EN3HANCE (liquid and spray) were bought from Du Pont-New 
England Nuclear, Dreieich. NG-(2-Aminoethyl)-cAMP-Sepharose, 
Percoll, and phenyl-Sepharose were obtained from Pharmacia, Frei- 
burg. Bacitracin was from Calbiochem. PI-PLC (Bacillus cereus) 
alkaline phosphatase (calf intestinal mucosa) was  from Boehringer, 
8-N3-[32P]cAMP, 8-azidoadenosine 3’:5’-mon0[~~P]phosphate; PI, 
The abbreviations used are: GPI, glycosyl-phosphatidylinositol; 
phosphatidylinositol; PL, phospholipase; GPI-PLC(D), glycosyl- 
phosphatidylinositol-specific phospholipase C(D); VSG, variant sur- 
face glycoprotein; CRD, cross-reacting determinant; PEG, polyeth- 
ylene glycol; PAGE, polyacrylamide gel electrophoresis; DTT, dithi- 
othreitol; MOPS, 3-(N-morpholino)propanesulfonic acid  (P)Pi,  in- 
organic (pyr0)phosphate; Triton X-100, octylphenol(ethy1ene 
glycolether),; Triton X-114, poly(ethy1ene glycol)8mono(octyl- 
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Mannheim. Highly purified GPI-PLC (Trypanosoma brucei), poly- 
clonal anti-VSG rabbit  antiserum 117, and  the soluble VSG antigen 
117, as well as anti-CRD antibody were gifts from P. Overath, 
Tubingen. GPI-PLD from rabbit serum and  PI-PLC from Bacillus 
thuringiensis were donated by  W. Gutensohn, Munchen. 12-0-Tetra- 
decanoylphorbol-13-acetate was bought from Serva, Heidelberg. 
Mixed ester cellulosic filters  (HAWP, 24-mm diameter and Millex 
HV, 0.45 pm) were purchased from Millipore, Eschborn. CAMP, PEG 
4000, tunicamycin, PLD (cabbage), and rhodamine 6G were bought 
from Sigma, Deisenhofen. Silica Gel G and "soft-plus'' Si-60 plates 
were  from Merck, Darmstadt. HF  and trifluoroacetic acid were from 
Riedel  de Haen, Seelze.  All other chemicals were obtained as described 
previously (18-22). 
Yeast Strains, Growth  Conditions, Preparation of Plasma 
Membranes 
Plasma membranes were isolated from total homogenates of lac- 
tate-grown cells (strain ABYS1;  Ref.  23) in the presence of protease 
inhibitors (20) by two successive density gradient centrifugations on 
Percoll(28%) and sucrose (15-28%), using the binding of radiolabeled 
concanavalin A as a criterion for recovery (17). Finally, the plasma 
membranes were spun through a cushion of  0.5 M sucrose and 
resuspended in SEM buffer (0.25 M sucrose, 1 mM EDTA, 20 mM 
MOPS/KOH, pH 7.4) at 2.5 mg/ml. Aliquots were frozen in liquid 
Nz and stored at -70  "C. 
Metabolic  Labeling 
ABYSl cells were  grown overnight (labeling to equilibrium) or for 
2 h (short  term)  at 30 "C in semisynthetic medium as described (17) 
or in phosphate-free lactate (3%) medium (for labeling with Pi) to 
an Am of 0.4, harvested and labeled with 0.75 (0.15) mCi of ["C] 
([3H])stearic acid or 0.5 (0.2) mCi of my~['~C]([~H])inositol or 0.4 
(0.1) mCi  of [I4C]( [3H])glucosamine or 0.35  mCi  of [14C]ethanolamine 
or 0.25 (0.1) mCi of ['4C]([3H])galactose or 0.1 (0.04) mCi of ["C] 
([3H])mannose or 0.08 mCi of 32Pi or with 0.5 mCi of [3H]palmitic 
acid plus 0.1  mCi  of my~-['~C]inositol (double labeling) for 1 h (short 
term labeling: Am = 0.10-0.15). For Pi labeling, NaF (25 mM, final 
concentration), glycerol 3-phosphate (50 mM, final concentration), 
ocadaic acid (0.5 pM, final concentration), and  KPP, (100 mM, final 
concentration) were added 2 min before termination of the labeling. 
Tunicamycin (final concentration of 30 pg/ml) was added 30 min 
before the labeled compound and  maintained  throughout he labeling 
period. 
Affinity Purification 
Up to 500 pg of plasma membrane protein was solubilized in 25 
mM MOPS/KOH, pH 7.0,150 mM NaC1,4 mM MgC12,0.4 mM EGTA, 
0.5 mM DTT, 0.5% decanoyl-N-methylglucamide, 0.1 mM 3-isobutyl- 
1-methylxanthine, 0.1 mM phenylmethanesulfonyl fluoride, 50 pM 
leupeptin, 0.1 mM aprotinin at 2 mg/ml, centrifuged (150,000 X g, 30 
min) and the  supernatant applied to a 2-ml column of w-(2-amino- 
ethyl)-CAMP-Sepharose as described (21) with the following modifi- 
cations. The column was washed five times with 2 ml of 25 mM 
MOPS/KOH, pH 7.2, 100 mM sodium citrate, 5 mM DTT, 5 mM 
MgClZ, 150 mM NaCl, 250 mM sucrose, 7.5% ethylene glycol, 10% 
glycerol, 1 mg/ml bovine serum albumin, 1 mM 3-isobutyl-1-meth- 
ylxanthine and eluted with 2 ml of the same buffer supplemented 
additionally with 100 mM CAMP at  4 "C. The initial 250 pl of the 
eluate was desalted by centrifugation through a 1-ml column of 
Sephadex G-25 equilibrated with 25 mM MOPS/KOH, pH 7.0, 50 
mM KCl, 5 mM MgC12, 10 mM DTT, 50 p M  EDTA, 50 p M  phenyl- 
methanesulfonyl fluoride, 0.1% deoxycholate, 5% glycerol and precip- 
itated with an equal volume of 8% PEG 4000 in  10 mM MOPS/KOH, 
pH 7.2, 1 mM EDTA (30 min, 4 "C). After centrifugation (15 min, 
4 "C, microcentrifuge) the pellet was dissolved in 20 mM MOPS/ 
KOH, pH 7.2, 1 mM EDTA, 100 p~ phenylmethanesulfonyl fluoride, 
0.5% deoxycholate at 2 mg/ml. 
Digestion  with Phospholipases 
5 units of partially purified PI-PLC (B.  cereus) (the activity cor- 
responds to 5 pmol of bovine acetylcholinesterase cleaved per min) 
in 300  pl of 20 mM Tris/HCl,  pH 7.5, 120 mM NaC1, 2 mM EDTA, 1 
mM DTT, 0.05% (v/v) Triton X-100,0.5 mg/ml phosphatidylcholine 
at 37 "C for 2  h (24); 0.2 units of purified PI-PLC  (E. thuringiensis) 
(1 unit defined as  the activity cleaving 1 pmol of PI/min  in Triton 
X-100) in 200 pl 5 mM potassium phosphate, 10 mM Tris/HCl,  pH 
7.4, 150 mM NaCl, 1 mM DTT, 0.1% Triton X-100 at 37 "C for 2  h 
(25); 5 p1 of partially purified GPI-PLC (from T. brucei ILTat 1.25, 
obtained from P. Overath, Tubingen (26)) in 100  pl of 25 mM Tris/ 
HCl, pH 8.0, 3 mM EDTA, 0.1% Triton X-100 at 37  "C for 1 h (27); 
15 pl of crude GPI-PLD (heparinized human serum) in 250 pl of 100 
mM Tris maleate, pH 7.4,  30 mM NaC1, 2 mM CaClZ, 0.1% Nonidet 
P-40 at 37 "C for 60 min (28); 50 units  (1  unit defined as  the activity 
which cleaves 1 pmol of phosphatidylcholine/min) PLD (cabbage) in 
500  pl of  20 mM potassium phosphate, pH 5.6, 125 mM CaC12,  0.05% 
Triton X-100 at 30 "C for 90 min (29) were alternatively used to 
cleave the anchor or fragments thereof. 
Pronase  Treatment 
Biosynthetically labeled and affinity-purified CAMP-binding pro- 
tein (from 250  pg  of plasma membranes), in 70 p1 of  25 mM MOPS/ 
KOH, pH 7.4, 0.5 mM EDTA, 0.5% deoxycholate, 5 mM DTT, was 
precipitated with 8% of PEG 6000, washed with acetone, dried under 
NZ gas, and dispersed in 150  pl of 100 mM (NH4)&03, pH 8.2, 1 mM 
CaC12, 0.05% octyl glucoside. Pronase was added initially and after 
12 h (10  mg each) and  the mixture incubated at  37 "C for 24 h with 
constant shaking. The digest was lyophilized and extracted three 
times with methanol/pyridine/water (2:l:l). The pooled extracts were 
adjusted to  pH 5 with acetic acid and loaded onto  a column (0.5 X 18 
cm) of octyl-Sepharose equilibrated with 0.1 M sodium acetate buffer, 
pH 5, containing 5% 1-propanol. The column was  washed with 10 ml 
of the same buffer and eluted with a 5-55% 1-propanol gradient at a 
flow rate of 1 ml/h. The GPI-peptide was repurified on octyl-Sepha- 
rose using batch elution with 32% 1-propanol in water. The GPI 
peptide-containing fraction was filtered through a Millex  HV  0.45- 
pm membrane, dried, redissolved in 500 pl of the sodium acetate 
buffer and refiltered. 
Glycanuse Treatment 
Denatured Membrane Proteins (According  to  Ref. 30 with the Fol- 
lowing M~difications-~H- or 14C-labeled, affinity-purified and precip- 
itated (8% PEG 6000) CAMP-binding protein (approximately 20 pg 
of protein) was dissolved in 0.1 M phosphate buffer, pH 8.6,  50 mM 
KCl, 25 mM DTT, 0.5% deoxycholate, 0.1% SDS and 0.75 M NaSCN 
and boiled for 5 min. The sample was diluted 10-fold with the same 
buffer lacking SDS and NaSCN and incubated with N-glycanase (5 
units/ml) in a total volume of 500 pl for 18 h, terminated by the 
addition of acetone, 0.07 M HCl together with 50  pg  of hemoglobin as 
a  carrier, followed  by centrifugation at 12,000 X g for 10 min. Acetone, 
0.07 M HCl, and ether-washed dry precipitates were analyzed by SDS- 
PAGE or subjected to further enzymic or chemical analyses as indi- 
cated. 
Native, Metabolically Labeled Membrane Proteins-Intact yeast 
cells (75,000 dpm) or spheroplasts (60,000 dpm) or isolated plasma 
membrane vesicles  (30,000 dpm) were incubated with 15 units/ml N- 
glycanase in 0.01 M sodium acetate, pH 5.1,O.l M P-mercaptoethanol, 
0.15 M NaSCN (total volume, 400 p1) at 30 "C. After 90 min another 
15 units/ml N-glycanase was added and  the incubation continued for 
3 h. Subsequently the cells/spheroplasts/vesicles were washed two 
times (centrifugation through a cushion of 0.25 M sucrose). Subse- 
quent cellular subfractionation was performed in the presence of a 4- 
fold molar excess of bovine trypsin  inhibitor and 100 pM phenylmeth- 
anesulfonyl fluoride. 
Binding to Phenyl-Sephurose (According  to  Ref.  31  with the 
Following  Modifications 
100  pl of sample in 900 pl of phosphate-buffered saline was incu- 
bated (25 "C, 1 h) with 75 p1 of phenyl-Sepharose beads. After washing 
(two times) in phosphate-buffered saline containing 0.01% Nonidet 
P-40 unbound material was recovered from the  supernatant (10,000 
rpm, 1 min, microcentrifuge). Material bound to the beads was 
extracted from the pellet by two  washes (15 min, 37 "C) with 450 p1 
of 2% Nonidet P-40 each. 
TLC  Analysis 
Purification of the Anchor Structure-Pronase-digestedanchor was 
chromatographed by TLC in chloroform/acetone/methanol/acetic 
acid/water (10:42:2:1, v/v). It was scraped off its position near the 
origin of the plate, extracted, and rechromatographed in chloroform/ 
methanol/ammonia/water (45:45:3.5:10, v/v) on oxalate-impregnated 
Silica Si-60 plates. Radiolabeled standard lipids were localized by 
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tivity was quantitated by linear TLC analyzer (Berthold). Alterna- 
tively, the radioactive material was scraped off the plate and evaluated 
by liquid scintillation counting. Nonradioactive phospholipid stand- 
ards were localized by spraying the plate with rhodamine 6G or 
exposing to iodine vapor. 
TLC  Analysis of Chemical and Enzymic Cleavage Products of the 
Anchor Structure-TLC was performed on Silica G plates activated 
at  125 "C for 2 h. The plates were  developed with solvent systems I- 
V as described I, petroleum ether/diethyl ether/acetic acid (70302, 
v/v); 11, acetone/petroleum ether (1:3, v/v) for the first development 
and chloroform/methanol/acetic acid/water (25:15:42, v/v) for the 
second development in the same direction); 111, chloroform/metha- 
nol/acetone/acetic acid/water (301040105, v/v); IV, petroleum 
ether/diethyl ether/acetic acid (80201, v/v); V, petroleum ether/ 
diethyl ether/acetic acid (80201, v/v) for the first development and 
toluene/methanol/acetic acid (80201, v/v) for the second develop- 
ment in the same direction. Radioactivity was determined by scraping 
0.5- X 0.5-cm  wide areas from the sample lanes and liquid scintillation 
counting in  10 ml  of Aquasol 2. Alternatively, the 3H- or "C-labeled 
products were detected by a TLC scanner. The positions of authentic 
unlabeled lipid standards, which cochromatographed as a mixture in 
a parallel lane on the same plate, were identified by spraying the 
plates with 80% (w/v) H2S04 and heating at  180 "C for 30 min. 
Hydroxamates were identified by spraying the chromatograms with 
FeC12 reagent. 
Extraction from Silica 
Radiolabeled material was extracted from silica gel (TLC plates or 
powder) by three washes with 2 ml of methanol followed  by one wash 
with 2 ml of chloroform/methanol/25% ammonia (2:1:0.075, v/v). 
After evaporation of combined extracts the lipids were  mixed with 50 
pl of H20, 150  pl of HCl and extracted with 300  pl of chloroform/ 
methanol (1:1, v/v). The organic phase was washed twice with 150  pl 
of methanol, 1 N HCl (kl, v/v), evaporated, and  the residue dissolved 
in the desired buffer. 
Extraction of the CAMP-binding Protein from Polyacrylamide 
Metabolically labeled and affinity-purified CAMP-binding protein 
(localized after SDS-PAGE by fluorography) was eluted from the 
respective gel  pieces  by electrophoresis and purified by  gel filtration 
(Sephadex G-50). Residual protein was eluted from the minced gel 
slices by two extractions with five gel volumes of  0.1 M Hepes/KOH, 
pH 8.0,0.1% SDS, 6 M urea and mixing overnight a t  56 "C. Combined 
eluates were dialyzed against water, concentrated (SpeedVac), and 
suspended in 25 mM MOPS/KOH, pH 7.4, 0.5 mM EDTA, 0.5% 
deoxycholate, 5 mM DTT. 
Purification of Polar Anchor Fragments 
The Pronase-digested CAMP-binding protein (GPI-peptide) was 
dephosphorylated with 60% (w/v) aqueous HF. Anions were  removed 
by a passage through 0.6 ml of AG3X4(OH-) on top of  0.2  ml  of  QAE- 
Sephadex A-25. The flow-through was adjusted to  pH 5 with 0.1 M 
sodium acetate, pH 5, filtered (0.2 pm membrane), dried, dissolved in 
the same buffer, and purified by a passage through a small column 
(1.5 X 20 cm) of Bio-Gel P-4 (400 mesh). The polar GPI core eluted 
from Bio-Gel P-4 at  a position equivalent to 6.8 glucose units. 
Carbohydrate-containing fractions were detected by spotting 2-pl 
aliquots onto silica TLC plates and staining with a-naphthol/H2S04. 
The anchor core was dried. 
Gas-Liquid Chromatographic Analyses 
The GPI-glycopeptides prepared from tunicamycin-treated cells 
were purified by octyl-Sepharose chromatography. Alternatively, the 
GPI-glycopeptide was dephosphorylated and  the polar glycan frag- 
ment separated from the apolar lipid fragment (see above). Dried 
samples (5-10 nmol of anchor) were treated with 60% (w/v) aqueous 
HF in polyethylene tubes at  0 "C for 16 h (32). HF was volatilized in 
vacuo over NaOH pellets in a glass-free system. Oligosaccharides were 
hydrolyzed (2 M trifluoroacetic acid, 4 h, 100 "C), sugars reduced (1% 
NaBH, in 0.1 M NH40H, 1 h, 37  "C) and acetylated (pyridine:acetic 
acid anhydride (l:l), 1 h, 60 '(2). Each sample received 25 nmol of 
xylose and 10 nmol of scyllo-inositol as internal yield standards before 
the  HF treatment. A separate  standard mixture containing 10 nmol 
each of glycerol, xylose, mannose, galactose, glucose, myo-inositol, 
scyllo-inositol, glucosamine, and galactosamine was treated identi- 
cally and run in parallel with each analysis. A blank sample was 
analyzed in addition. For the identification of glycerol, neutral sugars, 
and amino sugars the corresponding per-acetylated derivatives were 
separated using 3% SP 2340 on 100/120 Supelcoport (Supelco  Inc., 
Bellefonte, PA) and a Packard gas chromatograph, model 428, as 
described (33,34). 
Amino  Acid  Analysis 
Anchor fragments (2 nmol)  were sequentially hydrolyzed with 60% 
HF (see above) and 4 M HCl (16 h,  100 "C). Dried and resuspended 
samples were applied to the amino acid analyzer (Biotronic LC 6001) 
together with 2 nmol of m-diaminopimelic acid as  an internal  stand- 
ard. A separate standard mixture contained 2 nmol each of  m- 
diaminopimelic acid, ethanolamine, glucosamine, and asparagine. 
Evaluations were made by a Shimadzu integrator, model  C-R1A. 
Miscellaneous Methods 
Preparation of mitochondria, cytoplasm, separation of inside-out 
and outside-out plasma membrane vesicles (18, 20), the radioassay 
for acetylcholine esterase activity (35), photoaffinity labeling with 8- 
N3-[32P]~AMPor 8-N3-[3H]cAMP (17), hydrophobic/hydrophilicpar- 
titioning between a Triton X-114 and an aqueous phase (36), GPI 
analytical procedures such as base hydrolysis (37), acetolysis (38), 
nitrous acid deamination (9), periodate oxidation (8), dephosphoryl- 
ation by aqueous HF (40), and mild acid treatment for cleavage of 
inositol-1,2-cyclic phosphate esters (41), sodium carbohydrate extrac- 
tion of membrane proteins (42), Western blotting, immunoprecipi- 
tation (43), PAGE (5% (w/v) stacking gel and 14% (w/v) running gel 
in the presence of SDS and urea), and fluorography (44) and protein 
determination (45) were carried out according to published proce- 
dures. 
RESULTS 
The CAMP-binding Protein from Plasma Membranes Is 
Converted to a Soluble, Hydrophilic Version by Lipolytic  Cleav- 
age-The CAMP-binding protein from yeast plasma mem- 
branes (54 kDa)  can be specifically photoaffinity labeled with 
membrane-impermeable 8-N3-[32P]cAMP in spheroplasts 
(Fig. 1, lane 1 )  and in isolated plasma membrane vesicles 
(lanes 5 and 6 ) .  It  is accessible to digestion of N-glycosidic 
carbohydrate side chains by N-glycanase in  intact or sonicated 
spheroplasts (lanes 2 and 4 )  and outside-out plasma mem- 
brane vesicles ( l a n e  7). This  is evident from the reduction of 
its molecular mass to 41-44 kDa. Carbohydrate chains are 
inaccessible in inside-out plasma membrane vesicles where 
inversion of the membrane topology prevents access of the 
enzyme ( l a n e  5). These results confirm the previously de- 
scribed glycoprotein nature  and location of the cAMP receptor 
protein at  the outer face of the plasma membrane (17). Inter- 
estingly, the N-glycosidic carbohydrate side chains are not 
in cutout 
54kDa 
FIG. 1. Photoaffinity labeling of the plasma membrane 
CAMP-binding  protein. Yeast spheroplasts (lanes 1-4) or plasma 
membrane vesicles (PM, lanes 5-7) with outside-out (out) or inside- 
out (in) orientation were incubated in the presence or absence of N-  
glycanase (Gly) under native conditions. A portion of the spheroplasts 
was sonified during the digestion (ultrasonic bath, maximal intensity, 
three times for 10 s; son, lane 4 ) .  The spheroplasts (50 pg  of protein) 
and plasma membranes (5  pg  of protein) were  solubilized with 0.5% 
deoxycholate, photoaffinity labeled with 8-N3-[32P]cAMP in the ab- 
sence or presence of excess of unlabeled cAMP as indicated, and 
subjected to SDS-PAGE and fluorography.  Molecular masses, indi- 
cated on the left margin, were  derived  from marker proteins run  in 
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required  for  specific binding of cAMP  since  the fficiencies of 
photoaffinity labeling do  not differ significantly between the 
intact (54 kDa, lunes 1 and 6 )  and deglycosylated (44- and 41- 
kDa  fragments  in lunes 2 and 7 )  CAMP-binding protein. The 
occurrence of a similar CAMP-binding isoprotein (46 kDa, 
18-22) in  spheroplasts (lanes I ,  2, and 4 )  provides  a  versatile 
marker (in addition to adenylate cyclase) to assess mutual 
contamination of the two membrane fractions (see e.g. the 
absence of the mitochondrial receptor from plasma mem- 
branes (lanes 5-7). Photoaffinity labeling of intact sphero- 
plasts provides a convenient tool for  the selective  labeling of 
the plasma membrane cAMP receptor. The mitochondrial 
isoprotein is poorly  labeled under  these  conditions. 
Previous  studies (17) have shown that  the CAMP-binding 
plasma membrane protein is tightly membrane-associated 
since  it  can  be  extracted  neither  with  alkaline  carbonate  nor 
with high salt.  In  addition,  some evidence has been obtained 
that  membrane  anchorage of this  protein  is  mediated by a 
lipid structure.  In  Triton X-114 partitioning,  it behaved as  an 
amphiphilic protein and is recovered from the detergent- 
enriched phase. It is converted into a hydrophilic form by 
cleavage with PLC. To  analyze phospholipase specificity in 
greater  detail we treated solubilized plasma  membranes (Fig. 
2, filled bars) with phospholipases of different origin and 
assayed cleavage of the  anchor  in  comparison  with a  typical 
*IO,, I 
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Contml PLC 8.0. PLC 0.1. PLC T.b. PLD h.s. PLD r.s! PLD aab. 
Control PLC 0.0. PLC 8.1. PLC T.b. PLD h.s. PLD 1,s. PLD oab. 
FIG. 2. Lipolytic cleavage of the plasma membrane CAMP- 
binding protein. Solubilized, photoaffinity-labeled plasma mem- 
branes from yeast (50 pg  of protein, 7,000 dpm; filled bars) and bovine 
erythrocyte membranes (10 pg of protein; hatched  bars) were mock 
treated (Control) or incubated with PI-PLC from B. cerezu (PLC 
B.c.) or PI-PLC from B. thuringiensis (PLC B.t.) or GPI-PLC from 
T. brucei (PLC T.b.) or GPI-PLD from human (PLD h.s.) or rabbit 
serum (PLD r.s.) or PLD (cabbage). To one half of the reaction 
mixture phenyl-Sepharose was added, and  the material bound or not 
bound was analyzed (panel A ) .  The other half  was analyzed by Triton 
X-114 partitioning (panel B ) .  The radioactivity of the CAMP-binding 
protein and  the enzymic activity of acetylcholine esterase were meas- 
ured in the aqueous and detergent phases as well as in the fractions 
bound and not bound to phenyl-Sepharose, respectively. The sum 
was set at 100% in both instances. Only the fractions of CAMP- 
binding protein (filled  bars) and acetylcholine esterase (hatched bars) 
bound to phenyl-Sepharose and partitioned into  the aqueous phase 
are shown. Results were derived from four independent experiments. 
GPI-modified  protein, bovine erythrocyte acetylcholine ester- 
ase (hatched  bars). Amphiphilicity of the cleavage products 
was monitored  in two  aliquots. In  one  the  capacity  to  bind  to 
phenyl-Sepharose was measured (panel A )  and with the  other 
the behavior in Triton X-l14/aqueous phase partitioning 
(panel B ) .  With  phenyl-Sepharose only the  bound  fraction, 
with partitioning only the  fraction recovered from  the  deter- 
gent-depleted (aqueous)  phase,  is shown. It  can be seen  that 
the bovine and  the  yeast  proteins behave  similarly. They  are 
converted  to hydrophilic forms which partition  into  the 
aqueous phase  and  are  unable  to  bind  to  phenyl-Sepharose 
when treated with PI-PLC from B. cereus or B. thuringiensis 
or,  most efficiently,  with GPI-PLC  from T. brucei. GPI-PLDs 
from both  human  and  rabbit  serum also generate  the hydro- 
philic version of the two proteins,  albeit  to a  slightly lower 
extent. PLD from cabbage, which is not GPI-specific, has 
almost  no effect. The  generation of hydrophilic forms of both 
the yeast CAMP-binding protein and bovine acetylcholine 
esterase by the lipolytic treatment  strongly suggests anchor- 
age by a GPI structure also of the CAMP-binding protein. 
The lower efficiency of cleavage of the  yeast  anchor  as com- 
pared  with  the bovine anchor,  particularly  evident  with  PLC 
from B. cereus, may  reflect  some structural heterogeneity  (14). 
Metabolic Labeling of the Anchor Structure-To identify 
compounds of the lipidic anchor we used  metabolic  labeling 
of cells with typical anchor  constituents, D-myo-inositol, glu- 
cosamine, mannose, ethanolamine (Fig. 3A) and phosphate 
(Fig. 3B) .  A minor  component (54 kDa) of the  total  plasma 
membrane  fraction (panel A ,  lane 6 )  is labeled with  all  the 
sugar compounds and ethanolamine. This protein is highly 
enriched by affinity purification on CAMP-Sepharose. It  is 
photoaffinity labeled with 8-N3-[3'P]~AMP (lune 17) and 
represents  the major  metabolically  labeled plasma  membrane 
protein  eluted from the  cAMP  affinity column (lunes 5,  11, 
16, and 22). A separate series of experiments (not shown) 
reveals some metabolic interconversion of the  carbohydrates 
so that  the  radioactivity used  for  labeling is recovered from 
constituents of the Pronase-treated, purified anchor other 
than the one used for labeling. However, in any case we 
identified the  compound used  for  labeling as  the major  radio- 
active  constituent (> 70%) of the cleaved (Pronase), reisolated 
(two  consecutive TLC  runs  using  different  solvent  systems), 
and completely hydrolyzed anchor.' The comigration with  the 
authentic, photoaffinity-labeled protein  in  SDS-PAGE, cel- 
lular location, binding  to CAMP-Sepharose, and  simultaneous 
labeling by components  characteristic of GPI-moieties 
strongly argue in favor of the  identity of the labeled protein 
species  displayed in Fig. 3A with  the CAMP-binding protein. 
Radiolabeled putative  GPI  anchor compounds can  be  dis- 
criminated  from label residing in N-glycosidic side chains of 
the  cAMP  receptor by  metabolic  labeling of yeast cells in  the 
presence of tunicamycin which prevents attachment of N -  
glycosidic carbohydrate side chains  to  the  protein  or by their 
subsequent digestion with N-glycanase. Fig. 3A shows the 
fluorogram of an  SDS-PAGE of the affinity-purified CAMP- 
binding proteins. It can be seen that both, labeling in the 
presence of tunicamycin and treatment with N-glycanase, 
reduce the size of the labeled cAMP affinity-purified protein 
as expected for a glycoprotein (lanes 2 4 ,  8-10, 13-15, 19- 
21). However, in  all cases the core protein (41-44 kDa)  has 
retained at least some label as compared with the intact 
protein (lanes 5,  11, 16, and 22). To  test  whether  the label is 
associated  with  0-glycosidic  side chains or with a glycolipidic 
anchor,  the  protein  from  tunicamycin-treated cells  (44 kDa) 
was additionally exposed to aqueous HF, which cleaves phos- 
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FIG. 3. Metabolic labeling of the plasma membrane  CAMP- 
binding protein. Panel A ,  yeast cells were metabolically labeled 
(short term) with ["Clethanolamine (EthN),  ["Clmannose (Man), 
["C]glucosamine (GlcN), or myo-["C]inositol (Is) in the absence or 
presence of tunicamycin (Tun). Aliquots of the affinity-purified 
CAMP-binding protein (10 pg)  were left (lanes 3 ,5 ,9 ,  11,  14, 16,20, 
and 22) or treated with aqueous HF (lanes 1,4,  7,10,12,  15,18, and 
21) or digested with N-glycanase (lanes 2,8,13, and 19) as indicated. 
All samples were analyzed by SDS-PAGE and fluorography. Total 
plasma membranes photoaffinity labeled with 8-N3-[32P]cAMP ( L )  
and silver-stained (Ag)  were shown as controls. Molecular masses 
shown at  the left margin are derived from marker proteins run in 
parallel on the  the same gel. Panel B, yeast cells were metabolically 
labeled (to equilibrium) with [32P]Pi. Aliquots of affinity-purified 
CAMP-binding protein (5 pg  of protein) were digested with GPI-PLD 
from rabbit serum (PLD) or subjected to nitrous acid deamination or 
left untreated (first treatment). For the second treatment, the samples 
were incubated with 2.5 units/ml alkaline phosphatase (UP) for 60 
min at  37 "C or with aqueous HF  or left untreated. Each sample was 
partitioned  into  a detergent ( d )  or aqueous phase (a) .  Relevant phases 
were analyzed by SDS-PAGE and autoradiography. As a control, 
total 32P-labeled plasma membrane proteins ( to t )  are shown (lane 1 ). 
The molecular mass, indicated on the left margin, was derived from 
a parallel run of the authentic photoaffinity-labeled CAMP-binding 
protein. 
phodiesters  and removes the complete anchor  with  the excep- 
tion of ethanolamine.  This  dual  treatment removes most of 
the residual carbohydrate label including inositol (lanes I O ,  
15, and 21) whereas ethanolamine  remains unaffected (lane 
4 ) .  In  agreement,  treatment of the  intact CAMP-binding (54- 
kDa) protein with aqueous H F  alone releases most of the 
inositol (lane 18), significantly  reduces but does not  abolish 
the glucosamine and  mannose labeling (lanes 7 and I2),  and 
leaves the  ethanolamine labeling unaffected (lane 1 ). 
To examine incorporation of phosphate into the anchor 
structure we metabolically labeled yeast cells with [32P]Pi 
overnight  and purified the CAMP-binding protein by cAMP 
affinity  chromatography. To  discriminate between phosphate 
bound to the protein and to the lipid moiety, the CAMP- 
binding  protein was treated  first  with  nitrous acid or  GPI- 
PLD (Fig. 3B, first  treatment)  and  subsequently  with  alkaline 
phosphatase  or aqueous H F  (second treatment).  The  autora- 
diogram of the  SDS-PAGE of the  resulting  amphiphilic ( d )  
and hydrophilic (a )  forms of the  cAMP receptor separated by 
Triton X-114 partitioning  demonstrates  that  the  amphiphilic 
version of the  cAMP receptor can be  labeled with ["'PIP, (lane 
4 ) .  It  represents  only a minor  fraction of the  total  phosphate- 
labeled proteins from the plasma membrane (lane 1 ) but 
constitutes  the major  32P-labeled plasma  membrane  protein 
eluted  from  the CAMP-Sepharose column. Comigration of the 
photoaffinity-labeled and affinity-purified 32P-labeled protein 
strongly suggests identity  (data  not shown). The 32P label is 
largely resistant  to  treatment  with  alkaline  phosphatase (lane 
2 )  (under  conditions which completely  reverse  autophosphor- 
ylation of the mitochondrial CAMP-binding protein? This 
indicates that the majority of the ["PIP, is not bound to 
amino acids (serine  or  threonine). On the  other  hand,  treat- 
ment with  aqueous H F  leads to complete loss of the phospho- 
rus label (lane 3 ) .  Treatment of the 32P-labeled protein with 
GPI-PLD from rabbit  serum  or with nitrous acid  converts it 
to  the hydrophilic form (lanes 7 and 9) and simultaneously 
removes about 50% of the  total  phosphorus label (detergent 
plus aqueous phases) (compare lanes 4 and 5 (8,730 dpm) with 
lanes 7 and 8 (4,250 dpm)  and lanes 9 and 10 (3,120 dpm)). 
This suggests the presence of two phosphorus  atoms in the 
anchor. 
Analysis of the Isolated Anchor Structure-To confirm and 
extend the results obtained in the previous section and  to 
identify  constituents of the lipidic anchor directly, we sub- 
jected the purified and hydrolyzed structure to gas-liquid 
chromatography and amino acid analysis. For  this purpose 
plasma membranes were isolated from yeast cells grown in 
the absence or presence of tunicamycin. The  latter condition 
was chosen to avoid analytical  interference with constituents 
of N-glycosidic side chains  and  to  test possible effects of the 
antibiotic  on  the biosynthesis of the  anchor  structure. After 
solubilization of plasma membranes, the CAMP-binding pro- 
tein was purified by several steps including cAMP affinity 
and phenyl-Sepharose chromatographies  and igested to com- 
pletion with  Pronase. The  TLC-purified lipidic anchor frag- 
ment from the  preparation derived  from tunicamycin-treated 
cells was  reisolated, hydrolyzed, and directly  analyzed by gas- 
liquid chromatography (Fig. 4A and Table I). The anchor 
prepared from untreated cells was first cleaved with HF,  the 
polar fragment reisolated  from an  additional  TLC,  and  then 
analyzed as above (Fig. 4B and  Table I). Ninhydrin-positive 
compounds were identified by an  amino acid analysis (Fig. 5, 
A and B, and  Table  I). 
Although the two preparations shown  in Fig. 4, A and B, 
were derived  from two  different  yeast  cultures  and  represent 
differently treated  anchor  preparations,  the  results  are quali- 
tatively (Figs. 4 and 5) and  quantitatively  (Table  I) compa- 
rable. Fig. 4 shows that  the complete anchor  contains glycerol, 
myo-inositol, glucosamine, galactose, and mannose. Fig. 5 
reveals the presence of glucosamine and (in the complete 
anchor (Fig. 5 A )  but  not  in  the polar,  HF-cleaved  fragment 
(Fig. 5B) of ethanolamine,  aspartate,  and ammonia. The  latter 
two  compounds are derived  from the hydrolysis of asparagine. 
Ethanolamine  is coupled by an amide bond  to  the carboxyl- 
terminal amino acid of the  protein which in several cases, 
including  a yeast plasma membrane  protein of unknown  func- 
tion,  has been  identified as asparagine (15). Figs. 4. and 5A 
show the occurrence of constituents also  found  in GPIs from 
vertebrates  and some forms of trypanosoma1 VSGs including 
galactose, which branches off from  mannose proximal to  the 
glucosamine residue (5-9). The  quantitative recoveries of the 
constituents of the  anchor  are displayed in  Table I. Based on 
1 mol of myo-inositol (which is a very stable component in 
the  analytical procedure), the complete anchor  contains 1.8 
mol of glycerol, 2.5 mol  of mannose, 1.8 mol of galactose, 0.7 
mol of glucosamine, 0.9 mol of ethanolamine,  and 0.4 mol of 
aspartate.  The  amino acid appears  to have been removed, at  
least in part, from the  unpolar  anchor  during  the rigorous 
treatment  with  Pronase.  Taking  into consideration that  tri- 
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glucosamine  may have been decomposed  more in  the  anchor 
sample  than  in  the  standard  mixture,  the  molar  ratio may be 
approximated  to 1 glycero1:l rnyo-inositol:l glucosamine:3 
mannose: 2 galactose. This ratio of carbohydrates is addi- 
tionally confirmed by the  analysis of the  polar  fragment which 
lacks glycerol, ethanolamine,  and  aspartate.  The  approximate 
stoichiometry agrees  fairly well with a molecular mass  corre- 
sponding  to 6.8 glucose units  determined from elution of the 
metabolically labeled (my~-['~C]inositol) polar glycan frag- 
ment  (generated by aqueous HF treatment) from a Bio-Gel 
P-4 column (data  not  shown). 
Analytical  Approach  to  the  Structural  Arrangement of the 
Anchor-To study  the  structural  arrangement of the  constit- 
uents, we cleaved the  anchor  sequentially by five sequential 
chemical and enzymic reactions  and examined the cleavage 
products. In  this  experiment (Fig. 6) yeast cells were meta- 
bolically double-labeled with  i3Hlstearic acid (oDen bars) and 
1:. 12 
11.19 rny~-['~C]inositol (filled bars): * 
1 7 A; In  TLC  analysis (Fig. 6) of the purified anchor  (after 
. -  >gz 15.:35 i&'l affinity purification and Pronase digestion of the  protein), 
the  [3H]stearic acid and  the  rny~-['~C]inositol labels  comigrate 
1 '3 .59  lm-I s in  one  spot close to  the origin on  TLC (panel A, spot I; 
x. 5: '-Ins recovered almost  quan itatively).  Afternitrous acid deami- 
-GkN 
-Gk N 
FIG. 4. Gas-liquid chromatography of components of the 
anchor. The CAMP receptor protein was isolated from plasma mem- 
branes of cells grown in the absence or presence of tunicamycin (80 
pg/ml, added 6 h before harvesting of the cells), purified, and digested 
with Pronase. The anchor  structure was purified by TLC, hydrolyzed, 
and,  after reduction and acetylation, the per-acetylated polyols ana- 
lyzed  by gas-liquid chromatography together with xylose and scyllo- 
inositol as internal  standards. Gro, triacetyl glycerol; Man, hexaacetyl 
mannitol; Gal, hexaacetyl galactitol; m-Ins, hexaacetyl myo-inositol; 
GkN, heptaacetyl glucosaminitol; Xyl, pentaacetyl xylitol; s-Zns, 
hexaacetyl scyllo-inositol. Panel A, analysis of the complete anchor 
from tunicamycin-treated cells. Panel B,  analysis of the polar anchor 
fragment from untreated cells obtained after HF cleavage and reiso- 
lation from TLC. Further hydrolysis as above. 
nation of this material, the' cieaved double-labeled anchor 
structure  has a  less polar  character  and  migrates  to a  position 
coincident  with  the  phosphatidylinositol  standard (panel B, 
spot 111; spot I1 contains uncleaved starting  material).  This 
suggests direct linkage of phosphatidylinositol  to  nonacety- 
lated glucosamine. The  material reisolated  from spot 111 was 
then cleaved by PLD from  cabbage (panel C) or,  in  a different 
aliquot,  with PI-PLC from B. cereus  (panel D). The  almost 
complete loss of the rnyo-inositol label is observed in both 
cases. The I4C-labeled polar  material recovered at  the origin 
of the  TLC  plate  in  both  instances most likely is comprised 
of inositol (panel C) and 1,2-cyclic  inositol phosphate (panel 
D), respectively.  After the  alternative cleavage with PLD,  the 
[3H]stearic acid  label is retained in  a  compound which exhibits 
the  migration behavior of phosphatidic acid consistent with 
the enzyme's cleavage specificity (panel C, spot V). Treatment 
of the  other  aliquot with PI-PLC  shifts  the 3H-labeled spot 
to the position of the diacylglycerol standard as expected 
(panel D, spot VII; the efficiency of both lipolytic cleavages 
is about 50% as  can be seen from the  amount of uncleaved 
double-labeled PI,  spots IV and VI,  respectively). Subsequent 
acetolysis converts the major portion of the stearic acid- 
labeled PLD  reaction  product  (eluted from spot V) to a  less 
polar  structure,  comigrating  with  the diglyceride acetate 
standard in agreement with the exchange of phosphate in 
phosphatidic acid for acetate (panel E, spot VIII; again a 
significant  portion of the  starting  material,  spot  IX,  remains 
unaltered). The final base hydrolysis of the residual [3H] 
stearic acid-labeled anchor structures (spots VI11 and VI1 
combined)  generates a single 3H radioactive spot  (about 5% 
recovery of counts relative to  the  starting  material)  comigrat- 
ing with  the  stearic acid standard (panel F, spot X). This is 
consistent  with  the  almost complete  hydrolytic release of [3H] 
TABLE I 
Quantitative evaluation of anchor analyses 
The  total anchor of the CAMP-binding protein isolated from cells grown in the presence of tunicamycin (see legend to Fig. 4) and  the polar 
HF fragment isolated from cells grown in the absence of tunicamycin were purified as described under "Experimental Procedures" and 
analyzed by gas liquid chromatography and amino acid analysis as described in Figs. 4 and 5. Gror, triacetyl glycerol; Man, hexaacetyl 
mennitol; Gal, hexaacetyl galactitol; m-Ins, hexaacetyl myo-inositol; GlcN, heptaacetyl glucosaminitol; EthN, ethanolamine. 
Gas-liquid chromatography Amino acid analyzer 
Gro Man  Gal m-Ins GlcN GlcN ASP NH, EthN 
nmol/200 p l  nrno1/200 pl 
Total  anchor  (tunicamycin) 54.4 74.5 53.3 30.6 18.8 27.9 12.3 32.8 27.9 
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FIG. 6. TLC analysis of the  constituents of the  membrane 
anchor after sequential degradation. Affinity-purified CAMP- 
binding  protein  (from 500 pg of plasma  membranes),  double-labeled 
(short term) with [3H]stearic acid (open  bars) and  [‘4C]inositol (filled 
bars), was digested with Pronase. The anchor-containing structure 
was  analyzed  by  TLC (panel A,  solvent  system I). The anchor-derived, 
radiolabeled  material was eluted  and  subjected to the next  degradative 
step as detailed  under  “Experimental  Procedures.”  Material  recovered 
from spot I was sequentially subjected to nitrous acid deamination 
(panel B,  solvent  system 11), digestion  with  PLD  (cabbage) (panel C, 
solvent  system 111) or, alternatively, with PI-PLC (B .  cereus)  (panel 
D,  solvent  system 111). The material  eluted  from  spot V was  subjected 
to acetolysis (panel E,  solvent  system IV) and  finally to base  hydrol- 
ysis (panel F, solvent  system V). Radioactivity  values  after treatment 
with  PLD  and  PLC were  corrected  for the splitting of the  samples. 
Unlabeled  phosphatidylinositol (PI), 1,2-distearyl-3-acetylglycerol 
(DGA) ,  distearyl  phosphatidate ( P A ) ,  distearyl glycerol (DAG), and 
stearic acid (5 ’ )  standards were localized on the same plate with 
rhodamine 6G. The 3H and “ C  radioactivities of the affinity-purified 
CAMP-bindingprotein  (before  Pronase treatment) was taken as 100% 
(9,500 and 37,400 dpm,  respectively). o, origin; f ,  front. 
FIG. 5. Analysis of ninhydrin-positive components. The an- 
chor  was  purified as described  under  Fig. 4 and hydrolyzed. Panel A ,  
analysis of the complete  anchor  from  tunicamycin-treated  cells. Panel 
B,  analysis of the polar  anchor  fragment  from untreated cells  obtained 
after HF cleavage,  reisolation  from  TLC,  and  subsequent  hydrolysis. 
Asp, aspartic acid; Dap, diaminopimelic acid; GlcN, glucosamine; 
EthN, ethanolamine. 
stearic acid from  stearic acid-labeled diacylglycerol (spot  VII) 
and diglyceride acetate  (spot VIII). Taken  together,  the  amen- 
ability of the lipidic anchor  structure  to digestion with PLD 
and PI-PLC, acetolysis, and base hydrolysis demonstrates 
that  the  plasma  membrane CAMP-binding protein is cova- 
lently modified by phosphatidylinositol. The lipid is linked 
glycosidically to  nonacetylated glucosamine as revealed by 
cleavage at the glucosaminyl  residue after  nitrous acid deam- 
ination  as well as by carbohydrate  analysis of the  anchor.  The 
arrangement  is  consistent  with  the  structure of a GPI. 
To  elucidate  also  the  number  and  arrangement of phospho- 
rus  atoms  present  in  the glycan portion of the lipid anchor  in 
addition  to  the  one  in  phosphatidylinositol,  affinity-purified 
CAMP-binding protein from 32P-labeled cells was again di- 
gested with  Pronase,  the  anchor purified by two successive 
TLC  runs  with  different  solvent  systems  and  then  chromat- 
ographed a third  time by TLC using the basic solvent  system 
(Fig. 7A,  spot  I).  The reisolated anchor was then digested with 
GPI-PLD  from  rabbit  serum (panel B )  or GPI-PLC from T. 
brucei (panel C), respectively, followed again by TLC analysis 
of the cleavage products. 
After treatment  with GPI-PLD spot I is  converted  to two 
new, about equally strongly radiolabeled spots (Fig. 7B) .  The 
one  (spot IV) comigrates  with phosphatidic acid,  whereas the 
other  (spot 11) hardly leaves the origin. We conclude that  this 
latter highly polar  material  presumably  consists of the oligo- 
saccharide head group labeled with 32P at  the nonreducing 
end of its  terminal  sugar residue. The  sum of radioactivity 
recovered in  32P-labeled  phosphatidic acid plus  head group is 
approximately 45% (about 25% of the  anchor  structure  is  not 
attacked by GPI-PLD,  spot 111). This  finding suggests that 
the oligosaccharide head group harbors one phosphorus  atom/ 
mol, presumably as terminal  phosphorylethanolamine, 
whereas  the  other is present  in  the PI moiety. After  digestion 
with  GPI-PLC  from T. brucei (Fig. 7 C )  the major portion of 
32P label of the  anchor  structure  is recovered from a single 
polar cleavage product (spot V). It is likely to harbor both 
phosphorus atoms, since it contains about the sum of 32P 
radioactivity of spots I1 plus IV. The only other 32P-labeled 
compound (spot VI) comigrates with the uncleaved anchor 
structure.  This suggests that  the second cleavage product is 
unlabeled, presumably consisting of diacylglycerol. The oc- 
currence  and  structural  arrangement of wo phosphorus  atoms 
in  the lipidic anchor agree with a GPI  structure. 
Cross-reacting Immunological  Determinants in  the  GPI An- 
chors of  the  CAMP-binding  Protein  from  Yeast  Plasma  Mem- 
branes and VSG  from T. brucei-The above analyses suggest 
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FIG. 7. Incorporation of ['*Pi] into  the anchor structure of 
the CAMP-binding protein. Yeast cells were metabolically labeled 
(to equilibrium) with [32P]Pi. The affinity-purified CAMP-binding 
protein was digested with Pronase, the anchor purified by two se- 
quential TLCs,  and then chromatographed (solvent system 11) for a 
third time (panel A ,  uncleaved). Reeluted anchor material was di- 
gested with GPI-PLD from rabbit serum (panel B, PLD) or GPI- 
PLC from T. brucei (panel C, PLC). Radioactivity (triplicates) was 
evaluated by a linear TLC analyzer. Standard deviations are indi- 
cated. The positions of the standards (see legend to Fig. 6), indicated 
at  the top  of each run, were determined separately. 
components typically present in GPI anchors. To confirm 
further  the similarity to  GPIs from higher organisms in terms 
of structural arrangement and  to prove identity of epitopes, 
we examined immunological cross-reactivity to trypanosoma1 
CRD. Cross-reacting determinants were found to reside in the 
GPI anchors of the VSGs from different lines of trypanosomes 
expressing different VSGs (47, 48). One of the  determinants 
is constituted by the unmodified glucosamine of the anchor. 
Another one is formed by myo-inositol 1,2-cyclic phosphate 
generated upon cleavage by GPI-PLC (48). Since both of 
these determinants  are presumably also contained  in the yeast 
anchor, we reacted a protein blot of the affinity-purified 
cAMP receptor, pretreated with GPI-PLC  or GPI-PLD, with 
an anti-CRD  antiserum (Fig. 8A). 
In the control, the authentic, soluble VSG generates a 
strong signal at  the expected mobility corresponding to 60 
kDa (lane 1 ). Indeed, the affinity-purified, otherwise un- 
treated cAMP receptor yields a weak signal corresponding to 
a 54-kDa molecular mass (lane 3) which comigrates with the 
authentic photoaffinity-labeled CAMP-binding protein (lane 
2). The signal is enhanced severalfold upon cleavage of the 
anchor with GPI-PLC  dependent  on the concentration of the 
lipase (lanes 4 and 5). This indicates that removal of diacyl- 
glycerol generates or exposes an additional strong epitope, 
most likely the 1,2-cyclic phosphate  diester at  the myo-inositol 
which is formed by cleavage with GPI-PLC. Accordingly, no 
signal is obtained after cleavage with GPI-PLD (lane 11). 
The  PLC-treated cAMP receptor was subjected to various 
treatments known to affect the 1,2-cyclic phosphodiester 
bonds at the myo-inositol. As expected, oxidation of the 
carbohydrate moiety with periodate (lanes 6 and lo), phos- 
phodiester cleavage with aqueous HF (lane 7), and removal 
of phosphatidylinositol by nitrous acid (lane 9) eliminate 
recognition by the antibody. This reflects the fact that  the 
anti-CRD  antiserum recognizes cross-reacting determinants 
FIG. 8. Immunological characterization of the anchor  struc- 
ture. Panel A ,  affinity-purified CAMP-binding protein (from  100 pg 
of plasma membranes each) was incubated in the presence or absence 
of GPI-PLC (T. brucei; PLC) or GPI-PLD (rabbit serum; PLD) and 
subsequently subjected (treatment)  to periodate oxidation (PI) ,  
aqueous HF dephosphorylation (HF), mild acid hydrolysis (A ) ,  ni- 
trous acid deamination (NA),  or left untreated (-). Samples were 
separated by SDS-PAGE, transferred to nitrocellulose, incubated 
with polyclonal rabbit anti-117 VSG antiserum (dilution 1:500), and 
decorated with 1251-labeled mouse anti-rabbit IgG (D). As controls, 
0.5  pg  of soluble (GPI-PLC treated) VSG protein (lane I )  and 8-N3- 
[32P]cAMP photoaffinity-labeled plasma membranes (5,000 dpm, lane 
2) were run in parallel on the same gel. Following transfer, lane 2 
was cut off and directly autoradiographed without immunodecoration 
( P ) .  Molecular masses were derived from marker proteins run in 
parallel on the same gel. Panel B, solubilized plasma membranes 
photoaffinity labeled with 8-N3-[32P]cAMP (5,500 dpm) were incu- 
bated with GPI-PLC from T. brucei, concentrated, incubated with a 
1: lOO dilution of anti-117 VSG antiserum in the presence or absence 
of a 5 mM concentration of either myo-inositol 1,4,5-trisphosphate 
(I&), myo-inositol  1,Z-cyclic phosphate (ZP), glucosamine HC1 (C), 
or 10 pg of soluble VSG (V) (competition), precipitated with mouse 
anti-rabbit IgG-agarose and analyzed by SDS-PAGE and autoradi- 
ography. The molecular mass indicated is derived from total photo- 
affinity-labeled CAMP-binding protein run in parallel on the same 
gel. 
within the glycolipid and not within the protein moiety. 
Interestingly, also decyclization of the 1,2-cyclic phosphate 
ring by mild acid treatment reduces the reaction with anti- 
CRD antiserum to about 20% (lane 8) ,  comparable with the 
antibody reactivity of the uncleaved structure (lane 3). These 
results indicate that approximately 80% of the anti-CRD 
antibodies recognize inositol 1,2-cyclic phosphate in agree- 
ment with the  data obtained with authentic soluble VSG from 
trypanosomes (48) and suggest that  the anti-CRD epitope is 
located within the glucosaminyl-inositol phosphate  portion of 
the anchor structure of the CAMP-binding protein. 
Since it is important  to characterize this epitope from the 
yeast anchor in greater detail to be able to demonstrate 
similarity to  the respective structure from higher eucaryotes 
we measured the competition of antibody binding by constit- 
uents present  in  GPI. Binding was assayed by indirect im- 
munoprecipitation using anti-rabbit IgG-agarose.  Fig. 8B 
shows an autoradiogram of the electrophoretically separated 
immunoprecipitates. 
The anti-CRD antiserum immunoprecipitates the GPI- 
PLC-cleaved, photoaffinity-labeled CAMP-binding protein 
(lane 1 ). The specificity of the immunoprecipitation and  the 
immunological relationship between the  GPI anchors from 
VSG and from the CAMP-binding protein are best demon- 
strated by the efficient competition by excess soluble VSG 
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observed in  the  presence of rnyo-inositol-1,2-cyclic phosphate 
(lane 3 )  and glucosamine (lane 4 )  but  not  in  the  presence of 
inositol  trisphosphate (lane 2) proves that  these  constituents 
comprise  highly antigenic  determinants of the  anchors of both 
soluble VSG (48)  and  the CAMP-binding protein  from yeast. 
This  confirms  that  the two structures  are  either  identical or 
very closely related. 
DISCUSSION 
This  study provides the  first  detailed  structural  analysis of 
the lipidic membrane  anchor of a plasma  membrane  protein 
from a lower eucaryote, showing its close relatedness  to  GPIs 
from  higher  eucaryotes. S. cereuisiae harbors a 54-kDa glyco- 
protein bound to the outer face of the plasma membrane 
which binds  cAMP  with high affinity (17). It  is genetically 
unrelated to the regulatory subunit of cytoplasmic protein 
kinase A (43), which has  been  reported  to occur both  in a 
soluble and  membrane-associated  state.  The following obser- 
vations provide strong evidence that  anchorage of the  cAMP 
receptor protein is achieved through a GPI moiety. (i)  The 
CAMP-binding protein  is  amphiphilic like typical  GPI-modi- 
fied proteins. I t  is converted hydrophilic by bacterial PI- 
specific and trypanosoma1 GPI-specific phospholipases. (ii) 
The  protein  can  be m tabolically  labeled with  all  GPI-specific 
constituents.  The label is  preserved  in  the  presence of tuni- 
camycin and  resists deglycosylation  by  N-glycanase. All label, 
except  ethanolamine,  is  lost  from  the deglycosylated protein 
after  dephosphorylation  with  aqueous HF. (iii)  The metabolic 
labels can be recovered, at least in part, together with the 
anchor  after digestion of the  protein  with  Pronase. Analysis 
of the  anchor eveals the  presence of all  components  occurring 
in GPIs from higher eucaryotes. The almost quantitative 
release of the radiolabeled fatty acids from the diglyceride 
(acetate) moiety by alkaline hydrolysis suggests that both 
fatty  acids  are  linked  to glycerol via ester  bonds.  Since  nitrous 
acid  deamination  generates a 3H-fatty acid-labeled fragment 
which comigrates  on  TLC  with  PI,  the  inositol  ring  seems  to 
be unmodified. (iv) The hydrophilic form of the CAMP-bind- 
ing  protein  obtained  after  GPI-PLC digestion is recognized 
by antibodies  raised  against  the  (CRD of) soluble VSG from 
T. brucei both in immunodecoration and immunoprecipita- 
tion.  Cross-reacting  determinants reside in  the  anchor,  not  in 
the  protein moiety. 
These results strongly support the conclusion that the 
cAMP  receptor  protein  is  attached  to  the  plasma  membrane 
by a typical GPI  anchor.  The  presence of glycerol and  stearic 
acid excludes that the anchor contains sphingolipid. The 
occurrence of lipidic membrane  anchors  other  than  GPI (e.g. 
by fatty acids, ceramide-based anchors) has been reported 
(10,14).  In  fact,  it was  observed that  the  GPI-peptide  prepared 
by Pronase digestion of the  cAMP  affinity-purified  protein, 
which yielded a single protein  band  in  SDS-PAGE, was eluted 
in two peaks from a octyl-Sepharose  column  using a 1-pro- 
panol gradient. Only the major more hydrophobic second 
fraction was analyzed in this paper. Gas chromatographic 
analysis showed that  the  first  did  not  contain glycerol but a 
less  volatile, unidentified  component  instead  (data  not 
shown). This could be interpreted to mean that the same 
protein  carries  to  alternative  anchors,  one of which is a GPI, 
whereas the other could be a ceramide-based structure, as 
recently  described by Conzelmann et al. (14). 
The  variation  in  the labeling patterns  after labeling with 
anchor-specific compounds and the difference to the Coo- 
massie  Blue staining  pattern,  in  addition, provide  solid  evi- 
dence against the argument that the label may have been 
converted  to  other  compounds like amino acids. The proteins 
are  not  uniformly labeled. This is particularly  evident  from 
the  observation  that  three  essentially unlabeled proteins  (mo- 
lecular  masses of 68, 64, and 30 kDa)  can  be  eluted  from  the 
cAMP  affinity column together  with  the  cAMP receptor after 
labeling cells with inositol, glucosamine or ethanolamine.' 
The  nature of these polypeptides,  which were coeluted with 
the 54-kDa protein from the  cAMP  affinity column although 
they  do  not  bind  CAMP,  is  unknown.  Perhaps  they  represent 
components of a multisubunit cAMP receptor complex not 
dissociated during  affinity  purification. 
The  GPI-specific  arrangement of the  anchor of the  CAMP- 
binding  protein  is  particularly  underlined by the cross-reac- 
tivity  with a serum raised against soluble VSG from trypa- 
nosomes. Anti-CRD  antibodies  immunoprecipitate  GPI-mod- 
ified proteins only if a galactose branch is present in the 
carbohydrate moiety of the  PI-PLC-cleaved  anchor (46, 47) 
which,  in fact,  has been found by gas-liquid chromatography 
of the anchor constituents and by results obtained from 
metabolic  labeling of the  anchor  with [14C]galactose (data  not 
shown). Specific  chemical destruction of individual epitopes 
of the soluble cAMP receptor and competitive immunoprecip- 
itation  with single constituents of GPI  structures  indicate  the 
presence of at  least three overlapping epitopes which are 
responsible for the  cross-reactivity with the  anti-VSG  anti- 
bodies. They  are comprised by myo-inositol 1,2-cyclic phos- 
phate, the non-N-acetylated-glucosamine residue, and the 
galactose branch, consistent with the analysis of the VSG 
anchor (48). 
Thus,  GPI  anchors  are  similar or even identical in lower 
and higher  eucaryotes. The  identification of GPI  anchorage 
of an  increasing  number of ectoproteins from  higher eucary- 
otes and the conservation of such structures in evolution 
imply some  important biological function  about which little 
is known (for a review see Ref. 49). Yeast  provides  a  versatile 
and genetically manipulable model organism for the  study of 
the  biosynthesis  and physiological role of GPI  anchor  struc- 
tures. An example in which  lipidic anchorage  has regulatory 
implications on the protein's activity has been described 
recently in yeast mitochondria (21, 22). The protein binds 
cAMP  and is linked  to  the  outer face of the  inner  mitochon- 
drial  membrane by a  covalently attached P I  moiety  lacking 
carbohydrates.  It  appears likely that  it comprises the regula- 
tory  subunit of a  CAMP-dependent protein  kinase  but fails to 
release an active catalytic subunit in the membrane-bound 
state  despite  the  presence of CAMP. Incubation of isolated 
mitochondria with phospholipids or phorbolester in the  pres- 
ence of Ca2+  and  ATP  causes lipolytic cleavage of the  anchor 
and release of the  cAMP receptor into  the soluble intermem- 
brane space and  simultaneously leads to  the  activation of a 
soluble protein kinase in the intermembrane space which 
phosphorylates a 40-kDa  inner  membrane  protein  a CAMP- 
dependent  manner.  This implies that in this case membrane 
anchorage  controls  the  activity of a  CAMP-dependent protein 
kinase in a fashion in which lipolytic membrane release is 
epistatic  to  the dissociation of the complex by CAMP.  Unfor- 
tunately,  such a  regulatory  role  could not  yet be established 
for the membrane anchorage of the cAMP receptor from 
plasma  membranes of yeast. 
It  has  been observed, however, that lipolytic cleavage of the 
GPI  anchor of the  yeast  plasma  membrane  cAMP receptor 
by PI-PLC (B. cereus) causes a significant change in the 
pattern of amino acids, which can be photoaffinity labeled 
with  8-N3-[32P]~AMP.3  This may indicate a conformational 
alteration also in  the  plasma  membrane  protein moiety, pre- 
sumably accompanied by a functional change,  occurring upon 
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cleavage of the anchor. Similarly, in mammalian cells, the 
hormone-controlled release of GPI-anchored proteins from 
the  membrane surface has been  described for alkaline  phos- 
phatase,  heparansulfate proteoglycan, lipoprotein lipase, and 
Ei'-nucleotidase (7, 39, 50, 51). Currently we are  searching for 
physiological conditions  causing lipolytic cleavage of the  GPI 
anchor of the CAMP-binding protein  from  yeast  plasma  mem- 
branes. 
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